Omega Announces Pricing of Its $600,000,000 Senior Notes Offering
Omega intends to use the net proceeds from the offering for general corporate purposes, which may include, among other things, repayment of existing indebtedness and future acquisition or investment opportunities in healthcare-related real estate properties and to pay certain fees and expenses related to the Offering.
The 2030 Notes are guaranteed by Omega鈥檚 subsidiary, OHI Healthcare Properties Limited Partnership, and will be guaranteed by Omega鈥檚 existing and future subsidiaries that guarantee unsecured indebtedness for money borrowed of Omega in a principal amount at least equal to
Wells Fargo Securities, LLC, BofA Securities, Inc., Credit Agricole Securities (
The 2030 Notes will mature on July 1, 2030, have an issue price to the public of
The offering is being conducted by means of a prospectus supplement filed as part of a shelf registration statement on Form S-3 (Registration No. 333-282376) previously filed with the Securities and Exchange Commission (the 鈥淪EC鈥�). A copy of the preliminary prospectus supplement and accompanying prospectus relating to the offering of the Notes can be obtained from: Wells Fargo Securities, LLC, 608 2nd Avenue South, Suite 1000,
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Omega is a real estate investment trust (鈥淩EIT鈥�) that invests in the long-term healthcare industry, primarily in skilled nursing (鈥淪NFs鈥�) and assisted living facilities (鈥淎LFs鈥�). Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within
Forward-Looking Statements
This press release includes forward-looking statements within the meaning of the federal securities laws. All statements regarding Omega鈥檚 or its tenants鈥�, operators鈥�, borrowers鈥� or managers鈥� expected future financial condition, results of operations, cash flows, funds from operations, dividends and dividend plans, financing opportunities and plans, capital markets transactions, business strategy, budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, facility transitions, growth opportunities, expected lease income, continued qualification as a REIT, plans and objectives of management for future operations and statements that include words such as 鈥渁nticipate,鈥� 鈥渋f,鈥� 鈥渂elieve,鈥� 鈥減lan,鈥� 鈥渆stimate,鈥� 鈥渆xpect,鈥� 鈥渋ntend,鈥� 鈥渕ay,鈥� 鈥渃ould,鈥� 鈥渟hould,鈥� 鈥渨ill鈥� and other similar expressions are forward-looking statements. These forward-looking statements are inherently uncertain, and actual results may differ from Omega's expectations.
Omega鈥檚 actual results may differ materially from those reflected in such forward-looking statements as a result of a variety of factors, including, among other things: (i) uncertainties relating to the business operations of the operators of Omega鈥檚 properties, including those relating to reimbursement by third-party payors, regulatory matters, occupancy levels and quality of care, including the management of infectious diseases; (ii) the timing of our operators鈥� recovery from staffing shortages, increased costs and decreased occupancy resulting from inflation and the long-term impacts of the Novel coronavirus (鈥淐OVID-19鈥�) pandemic and the sufficiency of previous government support and current reimbursement rates to offset such costs and the conditions related thereto; (iii) additional regulatory and other changes in the healthcare sector, including potential changes to Medicaid or Medicare reimbursements, state regulatory initiatives or minimum staffing requirements for skilled nursing facilities (鈥淪NFs鈥�) that may further exacerbate labor and occupancy challenges for Omega鈥檚 operators; (iv) the ability of any of Omega鈥檚 operators in bankruptcy to reject unexpired lease obligations, modify the terms of Omega鈥檚 mortgages and impede the ability of Omega to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor鈥檚 obligations, and other costs and uncertainties associated with operator bankruptcies; (v) changes in tax laws and regulations affecting real estate investment trusts (鈥淩EITs鈥�), including as the result of any policy changes driven by the current focus on capital providers to the healthcare industry; (vi) Omega鈥檚 ability to re-lease, otherwise transition or sell underperforming assets or assets held for sale on a timely basis and on terms that allow Omega to realize the carrying value of these assets or to redeploy the proceeds therefrom on favorable terms, including due to the potential impact of changes in the SNF and assisted living facility (鈥淎LF鈥�) markets or local real estate conditions; (vii) the availability and cost of capital to Omega; (viii) changes in Omega鈥檚 credit ratings and the ratings of its debt securities; (ix) competition in the financing of healthcare facilities; (x) competition in the long-term healthcare industry and shifts in the perception of various types of long-term care facilities, including SNFs and ALFs; (xi) changes in the financial position of Omega鈥檚 operators; (xii) the effect of economic, regulatory and market conditions generally, and particularly in the healthcare industry and in jurisdictions where we conduct business, including the
We caution you that the foregoing list of important factors may not contain all the material factors that are important to you. Accordingly, readers should not place undue reliance on those statements. All forward-looking statements are based upon information available to us on the date of this release. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.
View source version on businesswire.com:
FOR FURTHER INFORMATION, CONTACT
Andrew Dorsey, VP, Corporate Strategy & Investor Relations, or
David Griffin, Director, Corporate Strategy & Investor Relations, at (410) 427-1705
Source: Omega Healthcare Investors, Inc.